Drug intelligence / Profile preview

Hudi Changrong

Development stage: Unknown
Lead developer: Jiangsu Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Hudi Changrong is a traditional Chinese medicine (TCM) formulation available as a capsule. It is used primarily for the treatment of mild active ulcerative colitis and is characterized in TCM by its heat-clearing and stasis-resolving properties, often prescribed for patients with heat-dampness and stasis blocked accompanied by spleen and stomach weakness. The exact herbal composition and molecular mechanism are not specified in the available sources. Clinical trials have been conducted to evaluate its efficacy and safety compared to standard treatments such as mesalazine[1][4]. The product is classified as a Chinese patent medicine.

Brand names: Hudi ChangrongHudi Changrong CapsuleHudi Changrong Jiaonang

Beyond the preview

Go deeper on Hudi Changrong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hudi Changrong.

Explore the full profile